Literature DB >> 30169868

Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.

David Fraguas1,2, Covadonga M Díaz-Caneja1,2, Miriam Ayora1,2, Fabián Hernández-Álvarez1, Alberto Rodríguez-Quiroga1, Sandra Recio1,2, Juan C Leza2,3, Celso Arango1,2.   

Abstract

Despite mixed findings, increasing evidence suggests that people with first-episode psychosis (FEP) show increased pro-inflammatory and pro-oxidative status. We used the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines to conduct a systematic literature search of cross-sectional studies comparing in vivo inflammatory and oxidative blood markers between FEP patients and healthy controls. We analyzed 61 independent samples from 59 publications, including 3002 patients with FEP (ie, patients with FEP, early psychosis, first-episode schizophrenia or early schizophrenia) and 2806 controls. After controlling for multiple comparisons, our meta-analysis showed that total antioxidant status and docosahexaenoic acid levels were significantly lower in FEP patients than in controls, whereas levels of homocysteine, interleukin-6 and tumor necrosis factor alpha were significantly higher in FEP patients than in controls. This suggests that FEP patients had reduced antioxidant status and a pro-inflammatory imbalance, and that these biological processes may be targets for managing FEP.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  biomarker; cytokine; first-episode psychosis; inflammatory; meta-analysis; oxidation; schizophrenia

Mesh:

Substances:

Year:  2019        PMID: 30169868      PMCID: PMC6581144          DOI: 10.1093/schbul/sby125

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   7.348


  53 in total

1.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

Review 2.  Inflammation in schizophrenia: A question of balance.

Authors:  Juan C Leza; Borja García-Bueno; Miquel Bioque; Celso Arango; Mara Parellada; Kim Do; Patricio O'Donnell; Miguel Bernardo
Journal:  Neurosci Biobehav Rev       Date:  2015-06-16       Impact factor: 8.989

Review 3.  Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder.

Authors:  Joaquim Radua; David Mataix-Cols
Journal:  Br J Psychiatry       Date:  2009-11       Impact factor: 9.319

4.  Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.

Authors:  Borja García-Bueno; Miquel Bioque; Karina S Mac-Dowell; M Fe Barcones; Monica Martínez-Cengotitabengoa; Laura Pina-Camacho; Roberto Rodríguez-Jiménez; Pilar A Sáiz; Carmen Castro; Amalia Lafuente; Javier Santabárbara; Ana González-Pinto; Mara Parellada; Gabriel Rubio; M Paz García-Portilla; Juan A Micó; Miguel Bernardo; Juan C Leza
Journal:  Schizophr Bull       Date:  2013-03-13       Impact factor: 9.306

5.  Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

Authors:  Iris E Sommer; Roos van Westrhenen; Marieke J H Begemann; Lot D de Witte; Stefan Leucht; René S Kahn
Journal:  Schizophr Bull       Date:  2013-10-08       Impact factor: 9.306

Review 6.  The neurobiology and treatment of first-episode schizophrenia.

Authors:  R S Kahn; I E Sommer
Journal:  Mol Psychiatry       Date:  2014-07-22       Impact factor: 15.992

Review 7.  Homocysteine levels in schizophrenia and affective disorders-focus on cognition.

Authors:  Ahmed A Moustafa; Doaa H Hewedi; Abeer M Eissa; Dorota Frydecka; Błażej Misiak
Journal:  Front Behav Neurosci       Date:  2014-10-06       Impact factor: 3.558

Review 8.  Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.

Authors:  M O Trépanier; K E Hopperton; R Mizrahi; N Mechawar; R P Bazinet
Journal:  Mol Psychiatry       Date:  2016-06-07       Impact factor: 15.992

9.  Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.

Authors:  C F M G van Kesteren; H Gremmels; L D de Witte; E M Hol; A R Van Gool; P G Falkai; R S Kahn; I E C Sommer
Journal:  Transl Psychiatry       Date:  2017-03-28       Impact factor: 6.222

10.  Levels of Serum Brain-Derived Neurotropic Factor in Individuals at Ultra-High Risk for Psychosis-Findings from the Longitudinal Youth at Risk Study (LYRIKS).

Authors:  Jie Yin Yee; Tih-Shih Lee; Jimmy Lee
Journal:  Int J Neuropsychopharmacol       Date:  2018-08-01       Impact factor: 5.176

View more
  41 in total

1.  The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia.

Authors:  Martina Ulivieri; Joanna Monika Wierońska; Luana Lionetto; Katiuscia Martinello; Paulina Cieslik; Agnieszka Chocyk; Martina Curto; Luisa Di Menna; Luisa Iacovelli; Anna Traficante; Francesca Liberatore; Giada Mascio; Nico Antenucci; Giuseppe Giannino; Matteo Vergassola; Anna Pittaluga; Valeria Bruno; Giuseppe Battaglia; Sergio Fucile; Maurizio Simmaco; Ferdinando Nicoletti; Andrzej Pilc; Francesco Fazio
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

2.  Clinical translational neuroimaging of the antioxidant effect of N-acetylcysteine on neural microstructure.

Authors:  Sue Y Yi; Brian R Barnett; McKenzie J Poetzel; Nicholas A Stowe; John-Paul J Yu
Journal:  Magn Reson Med       Date:  2021-09-30       Impact factor: 4.668

3.  GSK3β and mTORC1 Represent 2 Distinct Signaling Markers in Peripheral Blood Mononuclear Cells of Drug-Naive, First Episode of Psychosis Patients.

Authors:  Petros Petrikis; Alexandra Polyzou; Kyriaki Premeti; Argyro Roumelioti; Andreas Karampas; Georgios Georgiou; Dionysios Grigoriadis; George Leondaritis
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

Review 4.  Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity.

Authors:  Sophia Vinogradov; Matthew V Chafee; Erik Lee; Hirofumi Morishita
Journal:  Neuropsychopharmacology       Date:  2022-09-30       Impact factor: 8.294

5.  Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia.

Authors:  Mei Hong Xiu; Zezhi Li; Da Chun Chen; Song Chen; Maile E Curbo; Hanjing Emily Wu; Yong Sheng Tong; Shu Ping Tan; Xiang Yang Zhang
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

Review 6.  The origin of NMDA receptor hypofunction in schizophrenia.

Authors:  Kazu Nakazawa; Kiran Sapkota
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

7.  Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways.

Authors:  Karina S MacDowell; Eva Munarriz-Cuezva; J Javier Meana; Juan C Leza; Jorge E Ortega
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

8.  A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia.

Authors:  Kun Yang; Anouk Marsman; Subechhya Pradhan; Jennifer M Coughlin; Min Wang; Rebecca E Ward; Susanne Bonekamp; Emily B Ambinder; Cecilia P Higgs; Pearl K Kim; Jamie A Edwards; Mark Varvaris; Hongxing Wang; Sotirios Posporelis; Shuangchao Ma; Tsuyoshi Tsujimura; Richard A E Edden; Martin G Pomper; Thomas W Sedlak; Margot Fournier; David J Schretlen; Nicola G Cascella; Peter B Barker; Akira Sawa
Journal:  Mol Psychiatry       Date:  2020-10-19       Impact factor: 15.992

9.  Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.

Authors:  Xi Rong Li; Mei Hong Xiu; Xiao Ni Guan; Yue Chan Wang; Jun Wang; Edison Leung; Xiang Yang Zhang
Journal:  Neurotherapeutics       Date:  2021-03-31       Impact factor: 7.620

10.  Circulating Endothelial Progenitor Cells Are Preserved in Female Mice Exposed to Ambient Fine Particulate Matter Independent of Estrogen.

Authors:  Xuanyou Liu; Yichao Xiao; Qingyi Zhu; Yuqi Cui; Hong Hao; Meifang Wang; Peter J Cowan; Ronald J Korthuis; Guangfu Li; Qinghua Sun; Zhenguo Liu
Journal:  Int J Mol Sci       Date:  2021-07-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.